Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by DigitalSpurson Apr 29, 2020 4:35pm
182 Views
Post# 30968381

Huge day today!! (My thoughts on what the future brings)

Huge day today!! (My thoughts on what the future brings)I think today's announcement will be a catalyst for the FDA and the Australian Health Authority to take a step back, see what's happening in South Korea, see what's happening in Canada and say, let's go and give them the green light as well!!!!


On the call today on Zoom, the company mentioned it would be tough to get the go ahead in Canada and if they do get the go ahead in Canada, the US and Australia would soon follow.

Canada is known for it's strict and stringent measures and the world knows this. The actual drug isnt approved in Canada, so this is an amazing feat to get Health Canada to say, go ahead!!


My thoughts in the next week (yes the next week!!):
- We will get the OK from the FDA  to start the studies in America (The USA is a disaster for Covid now and they need it)
- We will get the ok from Australia to start the studies
- We may hear some news from South Korea that we don't have as many candidates as they wanted because they are doing a great job controlling the virus, but this is still speculative

Canada and the US still have a LOT of active cases and participation in this study should be very simple in terms of recruitment.

My predictions for tomorrow are an open at 55 cents and close of 67 cents. Remember the stock market is forward looking and it's only a matter of time before we get the go ahead from the FDA to start trials in the worst hit country in the world - and potentially going to get a lot worse from the recent decision to open businesses/schools/parks/beaches etc...



Bullboard Posts